학술논문
P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 1005-1006 (2022)
Subject
Language
English
ISSN
2572-9241